ENTRY       D11932            Mixture   Drug
NAME        Halobetasol and tazarotene;
            Ulobetsol and tazarotene;
            Duobrii (TN)
PRODUCT     DUOBRII (Bausch Health US)
COMPONENT   (Halobetasol propionate [DR:D04409] | Ulobetasol [DR:D08660]), Tazarotene [DR:D01132]
REMARK      ATC code: D05AX55
            Product: D11932<US>
EFFICACY    Anti-inflammatory
  DISEASE   Plaque psoriasis [DS:H01656]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D05 ANTIPSORIATICS
               D05A ANTIPSORIATICS FOR TOPICAL USE
                D05AX Other antipsoriatics for topical use
                 D05AX55 Tazarotene and ulobetasol
                  D11932  Halobetasol and tazarotene &lt;US&gt;
            USP drug classification [BR:br08302]
             Dermatological Agents
              Dermatological Agents, Other
               Psoriasis Agents
                Halobetasol Propionate/ Tazarotene
                 D11932  Halobetasol and tazarotene
///
